AMETEK, Inc.

(New York Stock Exchange)
Back to all articles
Bullish +65

BMO Capital Sees AMETEK (AME) Rebounding After Lagging 2025 Performance - Insider Monkey

AI-generated analysis

πŸ“ˆ BMO Capital analyst Daniel DiCicco initiated an Outperform rating on AMETEK with a $253 price target.

πŸ’° The firm expects consistent returns in the low-double-digit to mid-teens range driven by disciplined capital deployment.

πŸ” AMETEK is acquiring LKC Technologies to expand its Electronic Instruments Group's medical diagnostic capabilities.

πŸ“‰ The stock lagged the broader industrial group during 2025 but is expected to rebound in 2026.

🏭 AMETEK operates through two main segments: Electronic Instruments Group (EIG) and Electromechanical Group (EMG).

πŸ‘οΈ LKC Technologies specializes in portable devices for diagnosing diabetic retinopathy and monitoring eye health.

Bullish Signals
  • BMO Capital has initiated coverage with an Outperform rating, signaling strong institutional confidence.
  • The company is expected to deliver consistent returns ranging from the low-double-digits to mid-teens.
  • AMETEK possesses a diversified exposure to key structural themes across multiple industrial sectors.
  • The acquisition of LKC Technologies strengthens AMETEK's position in the growing medical diagnostics market.
  • Analysts view the stock as a core holding, suggesting long-term stability and reliability.
Full Analysis
BMO Capital analyst Daniel DiCicco initiated coverage of AMETEK, Inc. (NYSE: AME) on March 27 with an Outperform rating and a $253 price target. The analyst notes that while the stock underperformed the broader industrial group in 2025, it is well-positioned for growth in 2026 and beyond due to shorter-cycle businesses bottoming out and the company's diversified exposure to structural themes. The firm highlights AMETEK's disciplined capital deployment as a key driver expected to support consistent returns in the low-double-digit to mid-teens range. Consequently, BMO views the stock as a core holding for investors seeking stability and growth within the industrial sector. In February, AMETEK announced the acquisition of LKC Technologies, a provider of portable diagnostic devices for ophthalmic conditions based in Germantown, Maryland. This acquisition will integrate into AMETEK's Electronic Instruments Group (EIG), expanding its portfolio of advanced analytical and test instrumentation across aerospace, medical, power, energy, research, and industrial markets.